Cargando…

Random forest to differentiate dementia with Lewy bodies from Alzheimer's disease

INTRODUCTION: The aim of this study was to build a random forest classifier to improve the diagnostic accuracy in differentiating dementia with Lewy bodies (DLB) from Alzheimer's disease (AD) and to quantify the relevance of multimodal diagnostic measures, with a focus on electroencephalography...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dauwan, Meenakshi, van der Zande, Jessica J., van Dellen, Edwin, Sommer, Iris E.C., Scheltens, Philip, Lemstra, Afina W., Stam, Cornelis J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Diagnostic Assessment & Prognosis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050257/ https://www.ncbi.nlm.nih.gov/pubmed/27722196 http://dx.doi.org/10.1016/j.dadm.2016.07.003

Ejemplares similares

Evaluating combinations of diagnostic tests to discriminate different dementia types
por: Bruun, Marie, et al.
Publicado: (2018)

Clinico‐pathological comparison of patients with autopsy‐confirmed Alzheimer's disease, dementia with Lewy bodies, and mixed pathology
por: Chatterjee, Atri, et al.
Publicado: (2021)

Improving the clinical detection of Lewy body dementia with the Lewy body composite risk score
por: Galvin, James E.
Publicado: (2015)

Understanding hallucinations in probable Alzheimer's disease: Very low prevalence rates in a tertiary memory clinic
por: Linszen, Mascha M.J., et al.
Publicado: (2018)

Dementia with Lewy bodies research consortia: A global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working group
por: D'Antonio, Fabrizia, et al.
Publicado: (2021)

Hospitalization in people with dementia with Lewy bodies: Frequency, duration, and cost implications
por: Mueller, Christoph, et al.
Publicado: (2017)

Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
por: Jutkowitz, Eric, et al.
Publicado: (2020)

Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design
por: de Wilde, Arno, et al.
Publicado: (2017)

EEG Characteristics of Dementia With Lewy Bodies, Alzheimer’s Disease and Mixed Pathology
por: van der Zande, Jessica J., et al.
Publicado: (2018)

Detecting functional decline from normal aging to dementia: Development and validation of a short version of the Amsterdam IADL Questionnaire
por: Jutten, Roos J., et al.
Publicado: (2017)

Validation into Arabic versions of Dementia Rating Scales, Dementia Caregivers Scales, and Dementia Research Instruments
por: Karam, Georges Elie, et al.
Publicado: (2018)

The Quick Dementia Rating System (QDRS): A rapid dementia staging tool
por: Galvin, James E.
Publicado: (2015)

Optimizing cCOG, a Web‐based tool, to detect dementia with Lewy Bodies
por: van Gils, Aniek M., et al.
Publicado: (2022)

The CAIDE Dementia Risk Score App: The development of an evidence-based mobile application to predict the risk of dementia
por: Sindi, Shireen, et al.
Publicado: (2015)

Carers' diaries in dementia: Is there a role in clinical practice?
por: Jayalath, Dilini, et al.
Publicado: (2016)

Identifying memory impairment and early dementia in primary care
por: Grober, Ellen, et al.
Publicado: (2017)

Neuropsychiatric symptoms in Brazilians with mild cognitive impairment and dementia
por: Wilson, Robert S., et al.
Publicado: (2021)

Predicting disease progression in behavioral variant frontotemporal dementia
por: Anderl‐Straub, Sarah, et al.
Publicado: (2021)

Traits of patients who screen positive for dementia and refuse diagnostic assessment
por: Fowler, Nicole R., et al.
Publicado: (2015)

Predicting time to dementia using a quantitative template of disease progression
por: Bilgel, Murat, et al.
Publicado: (2019)

Sex-specific incident dementia in patients with central nervous system trauma
por: Mollayeva, Tatyana, et al.
Publicado: (2019)

Development of a dementia prediction model for primary care: The Hisayama Study
por: Honda, Takanori, et al.
Publicado: (2021)

The Vulnerability Index: A weighted measure of dementia and cognitive impairment risk
por: Kleiman, Michael J., et al.
Publicado: (2021)

Alzheimer's disease severity, objectively determined and measured
por: Gross, Alden L., et al.
Publicado: (2016)

Prognostic value of ATN Alzheimer biomarkers: 60‐month follow‐up results from the Argentine Alzheimer's Disease Neuroimaging Initiative
por: Allegri, Ricardo F., et al.
Publicado: (2020)

Mild cognitive impairment and dementia prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study
por: Knopman, David S., et al.
Publicado: (2016)

Subjective memory impairment: No suitable criteria for case-finding of dementia in primary care
por: Eichler, Tilly, et al.
Publicado: (2015)

An individual with human immunodeficiency virus, dementia, and central nervous system amyloid deposition
por: Turner, Raymond Scott, et al.
Publicado: (2016)

Dual sensory impairment in older adults and risk of dementia from the GEM Study
por: Hwang, Phillip H., et al.
Publicado: (2020)

Prevalence and clinical correlates of dementia among COVID‐19‐related deaths in Italy
por: Canevelli, Marco, et al.
Publicado: (2020)

Function and clinical meaningfulness of treatments for mild Alzheimer's disease
por: Siemers, Eric, et al.
Publicado: (2016)

Revolutionizing Alzheimer's disease and clinical trials through biomarkers
por: Mattsson, Niklas, et al.
Publicado: (2015)

Detection of presymptomatic Alzheimer's disease through breath biomarkers
por: Emam, Shadi, et al.
Publicado: (2020)

Is diabetes associated with increased pathological burden in Alzheimer's disease?
por: Sadrolashrafi, Kaviyon, et al.
Publicado: (2021)

Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer's disease in non‐demented adults
por: Ennis, Gilda E., et al.
Publicado: (2021)

Multi‐time‐point data preparation robustly reveals MCI and dementia risk factors
por: Kaur, Daman, et al.
Publicado: (2020)

The power of knowledge about dementia in Latin America across health professionals working on aging
por: Ibanez, Agustin, et al.
Publicado: (2020)

Periodontal disease's contribution to Alzheimer's disease progression in Down syndrome
por: Kamer, Angela R., et al.
Publicado: (2016)

Challenges associated with biomarker-based classification systems for Alzheimer's disease
por: Illán-Gala, Ignacio, et al.
Publicado: (2018)

Development and validation of a salivary tau biomarker in Alzheimer's disease
por: Pekeles, Heather, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hj2lu7cukhev6cu6hkv4ae5ju5